Key result
Antiplatelet therapy in ACS demands balancing ischemic benefits with bleeding risks from age and comorbidities.
Why the study?
Estimating the safety/efficacy tipping point of antiplatelet therapy in ACS patients remains a major challenge influenced by multiple factors including age and comorbidity.
This review outlines the development, mechanisms, evidence base, and clinical indications of antiplatelet therapy in acute coronary syndromes.
Reinforces individualized antiplatelet decisions in ACS; extends the evidence base via integrated mechanistic and clinical synthesis.
Antiplatelet therapy is an essential component in the treatment of acute coronary syndromes (ACS). ACS management has evolved significantly over recent years with new antiplatelet agents with distinct pharmacological properties that offer a faster onset of action and greater potency. Prospective randomized controlled trials have not only focused on reducing ischemic events, but also on complications. There is a tipping point with safety/efficacy, beyond which bleeding risk can outweigh any anti‐ischemic benefit. This tipping point is not fixed and estimating its position for an individual patient remains a major challenge and is critically influenced by a multitude of factors including age and comorbidity. The European Society of Cardiology (ESC) guidelines provide important direction to the trainee and practicing cardiologist. This article outlines development in antiplatelet therapy focusing on mechanism of action, the evolution in the evidence‐base, clinical indications, and clinical controversies. Answer questions and earn CME: https://wileyhealthlearning.com/Activity2/5222689/Activity.aspx
No takes yet. Share an insight, caveat, or question.
Brown et al. (2017) conducted a review in acute coronary syndromes (ACS). Antiplatelet therapy was evaluated. Antiplatelet therapy in acute coronary syndromes requires balancing ischemic benefit with bleeding risk, which is influenced by factors including age and comorbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: